There were 2,302 press releases posted in the last 24 hours and 441,177 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Sorrento Therapeutics Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) Epidural in Cancer Patients with Reported Intractable Pain

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image